The preventive effects of dexmedetomidine against intestinal ischemia-reperfusion injury in Wistar rats

Document Type: Original Article


1 Department of Anesthesiology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China

2 Grade 2012 of Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi 330006, China

3 Intensive Care Unit (ICU), First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China


Objective(s): Intestinal ischemia-reperfusion is a major problem, which may lead to multiorgan failure and death. The aim of this study was to evaluate the protective effects of dexmedetomidine on cell proliferation, antioxidant system, cell death, and structural integrity in intestinal injury induced by ischemia-reperfusion in rats.
Materials and Methods: Animals were randomized into three groups: group A, sham-operated or control; group B, intestinal ischemia/reperfusion (IR); and group C, intestinal IR pretreated with 50 μg of dexmedetomidine. Intestine tissue was collected from all rats 30 min after desufflation, and fresh frozen for histological and biochemical evaluation.
Results: The intestinal tissue of group B rats showed a significant decrease in the antioxidant             enzyme activities. However, these enzyme activities were improved by the administration of dexmedetomidine. Inhibiting the protein expression of MCP7, PAR2, P-JAK, P-STAT1, and P-STAT3 proved the protective effect of dexmedetomidine. The immunohistochemical staining revealed its protective effect by maintaining the normal structural integrity, less caspase-3 immuno reactivity, and increased cell proliferation count in the intestinal tissues.
Conclusions: Intraperitoneal injection of dexmedetomidine significantly protected intestine IR injury in rats by inhibiting the inflammatory response, intestinal epithelial apoptosis, and maintaining structural integrity of intestinal cells.


1. Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the ‘motor’ of critical illness. Shock 2007; 28:384-393.

2. Noda T, Iwakiri R, Fujimoto K, Matsuo S, Aw TY. Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol 1998; 274:270-276.

3. Kacmaz M, Ozturk HS, Karaayvaz M, Güven C, Durak I. Enzymatic antioxidant defence mechanism in rat intestinal tissueis changed after ischemia-reperfusion. Effects of an allopurinol plus antioxidant combination. Can J Surg 1999; 42:427-431.

4. Fujise T, Iwakiri R, Amemori S, Kakimoto T, Yokoyama F, Sakata Y, et al. Apoptotic pathway in the rat small intestinal mucosa is different between fasting and ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2006; 291:G110–116.

5. Kazez A, Demirbag M, Ustündağ B, Ozercan IH, Sağlam M. The role of melatonin in prevention of intestinal ischemia-reperfusioninjury in rats. J Pediatr Surg 2000; 35:1444-1448.

6. Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011; 15:R153.

7. Yoshitomi O, Cho S, Hara T, Shibata I, Maekawa T, Ureshino H, et al. Direct protective effects of dexmedetomidine against myocardial ischemia reperfusion injury in anesthetized pigs. Shock 2012; 38:92-97.

8. Zhang XY, Liu ZM, Wen SH, Li YS, Li Y, Yao X, et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology 2012; 116:1035-1046.

9. Paris A, Tonner P. Dexmedetomidine in anaesthesia. Curr Opin Anesthesiol 2005; 18: 412-418

10. Inci F, Dogan IV, Eti Z, Deniz M, Gogus Y. The effects of dexmedetomidine infusion on the formation of reactive oxygen species during mesenteric ischemia-reperfusion injury in rats. Marmara Med J 2007; 20: 154-160.

11. Andoh A, Fujiyama Y, Araki Y, Kimura T, Tsujikawa T, Bamba T. Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats. Digestion 2001; 63:103-107.

12. Bischoff SC. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009; 31:185.

13. Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 2009; 182:647.

14. Oshea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002; 109:S121YS131.

15. Schindler C, Strehlow I. Cytokines and STAT signaling. Adv Pharmacol 2000; 47:113Y174.

16. Si Y, Bao H, Han L, Shi H, Zhang Y, Xu L, et al. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation. J Transl Med 2013; 11:141.

17. Fu XB, Sheng ZY, Wang YP, Wang Y, Ye Y, Xu M, et al. Basic fibroblast growth factor reduces the gut and liver morphologic and functional injuries after ischemia and reperfusion. J Trauma 1997; 42:1080-1085.

18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.

19. Aebi H. Catalase in vitro. Meth Enzymol 1984; 105: 121-126.

20. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem1988; 34: 497-500.

21. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 79:588-590.

22. Albayrak Y, Halici Z, Odabasoglu F, Unal D, Keles ON, Malkoc I, et al. The effects of testosterone on intestinal ischemia/reperfusion in rats. J Invest Surg 2011; 24:283-291.

23. Carden DL, Granger DN. Pathophysiology of  ischaemiareperfusion injury. J Pathol 2000; 190:255-266.

24. Antonsson JB, Fiddian-Green RG. The role of the gut in shock and multiple system organ failure. Eur J Surg 1991; 157:3-12. 

25. Penissi AB, Rudolph MI. Piezzi RS. Role of mast cells in gastrointestinal mucosal defense. Biocell 2003; 27:163-172.

26. Yuan Y, Guo H, Zhang Y, Zhou D, Gan P, Liang DM, et al. Protective effects of L-carnitine on intestinal ischemia/reperfusion injury in a rat model. J Clin Med Res 2011; 3:78-84.

27. Dong W, Li F, Pan Z, Liu S, Yu H, Wang X, et al. Resveratrol ameliorates subacute intestinal ischemia-reperfusion injury. J Surg Res 2013; 185:182-189.

28. Boros M, Ordogh B, Kaszaki J, Nagy S. The role of mast cell degranulation in ischaemia-reperfusion-induced mucosal injury in the small intestine. Ann Acad Med Singapore 1999; 28:79-84.

29. Yoshida N, Takagi T, Isozaki Y, Suzuki T, Ichikawa H, Yoshikawa T. Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfu-sion injury in rats. Mol Med Rep 2011; 4: 81-86.

30. Yang N, Luo M, Li R, Huang Y, Zhang R, Wu Q, et al: Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrol Dial Transplant 2008; 23:91Y100.

31. Guneli E, Cavdar Z, Islekel H, Sarioglu S, Erbayraktar S, Kiray M, et al. Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. Mol Med 2007; 13:509-517.

32. da Silva AL, Kinsky MP. Dexmedetomidine alters the cardiovascular response during infra-renal aortic cross-clamping in sevoflurane-anesthetized dogs. J Invest Surg 2008; 21:360-368.

33. Braz LG, Braz JR, Castiglia YM, Vianna PT, Vane LA, Módolo NS, et al. Dexmedetomidine alters the cardiovascular response during infra-renal aortic cross-clamping in sevoflurane-anesthetized dogs. J Invest Surg 2008; 21:360-368.

34. Potten CS, Booth C. The role of radiation-induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: a brief review. Comp Biochem Physiol B Biochem Mol Biol 1997; 118:73-78.

35. Xu LF, Li J, Sun M, Sun HW. Expression of intestinal trefoil factor, proliferating cell nuclear antigen and histological changes in intestine of rats after intrauterine asphyxia. World J Gastroenterol 2005; 11:2291-2295.